• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GID
Click for more information
0.00% 0.2¢

GI DYNAMICS, INC - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
GIDInformation disclosed under ASX Listing Rule 3.10.5A30/08/13
GIDRelease of Securities from ASX Escrow22/08/13
GIDChange in substantial holding14/08/13
GIDCeasing to be a substantial holder13/08/13
GIDChange in substantial holding13/08/13
GIDChange in substantial holding13/08/13
GIDChange in substantial holding13/08/13
GIDChange in substantial holding13/08/13
GIDCleansing Notice09/08/13
GIDAppendix 3B09/08/13
GIDGI Dynamics to Present at Canaccord Genuity Conference08/08/13
GIDChange of Director's Interest Notice07/08/13
GIDChange of Director's Interest Notice07/08/13
GIDAppendix 3B07/08/13
GIDForm604 Notice of change of interests of substantial holder06/08/13
GIDResults of Meeting01/08/13
GIDAppendix 4C - quarterlyPRICE SENSITIVE31/07/13
GIDSpecial Meeting of Stockholders Conference Call24/07/13
GIDSecurity Purchase Plan12/07/13
GIDNotice of Extraordinary General Meeting/Proxy Form12/07/13
GIDBecoming a substantial holder12/07/13
GIDAppendix 3B11/07/13
GIDForm604 Notice of change of interests of substantial holder11/07/13
GIDCleansing Notice10/07/13
GIDDetails of Company Address05/07/13
GIDGI Dynamics Investor Presentation03/07/13
GIDGI Dynamics Completes A$57.5 MIillion Private PlacementPRICE SENSITIVE03/07/13
GIDTrading HaltPRICE SENSITIVE01/07/13
GIDGI Dynamics, Inc. Appoints Distributor for the Middle EastPRICE SENSITIVE26/06/13
GIDFrench Government Approves and Funds Two-Year Clinical StudyPRICE SENSITIVE19/06/13
GIDNew Commercial Centres in the European UnionPRICE SENSITIVE18/06/13
GIDAppendix 3BPRICE SENSITIVE06/06/13
GIDResults of Meeting20/05/13
GIDAnnual General Meeting Presentation and Webcast20/05/13
GID2013 Annual General Meeting Webcast/Conference Call14/05/13
GIDGI Dynamics names David Maggs, M.D. as Chief Medical Officer01/05/13
GIDNotice of Annual Meeting/Proxy Form30/04/13
GIDAppendix 4C - quarterlyPRICE SENSITIVE30/04/13
GIDChange in substantial holding26/04/13
GIDGI Dynamics, Inc. Reports on Progress of the ENDO TrialPRICE SENSITIVE26/04/13
GIDAppendix 3B12/04/13
GIDAnnual Report to shareholders28/03/13
GIDDetails of Company Address28/03/13
GIDChange of Directors Interest Notice19/03/13
GIDAppendix 3B19/03/13
GIDEndoBarrier Named Product of the Year by BioSpectrum Asia18/03/13
GIDChange of Director's Interest Notice12/03/13
GIDChange of Director's Interest Notice12/03/13
GIDCMS Medical to Distribute EndoBarrier Therapy in Brazil06/03/13
GIDPreliminary Final ReportPRICE SENSITIVE28/02/13
GIDCommercial Availability of EndoBarrier Therapy in IsraelPRICE SENSITIVE27/02/13
GIDGI Dynamics to Present at the Cowen Healthcare Conference27/02/13
GIDChange of Director's Interest Notice26/02/13
GIDChange of Director's Interest Notice26/02/13
GIDBriefing Call and Webcast on Financial Results for 201220/02/13
GIDRelease of Securities from Voluntary Escrow19/02/13
GIDEndoBarrier Therapy effect on mildly obese patientsPRICE SENSITIVE01/02/13
GIDAppendix 4C - quarterlyPRICE SENSITIVE30/01/13
GIDAppendix 3B18/01/13
GIDU.S. Pivotal Clinical Trial of EndoBarrier InitiatedPRICE SENSITIVE15/01/13
GIDGI Dynamics Announces Resolution of Litigation with GorePRICE SENSITIVE10/01/13
GIDGI Dynamics Announces Research CollaborationsPRICE SENSITIVE04/01/13
GIDChange of Director's Interest Notice19/12/12
GIDForm604 Notice of Change of interests of substantial holder03/12/12
GIDRelease of Securities from Voluntary Escrow27/11/12
GIDAppendix 3B22/11/12
GIDGID to Present at Lazard and Canaccord Hlthcare Conferences07/11/12
GIDForm604 Notice of change of interests of substantial holder02/11/12
GIDForm604 Notice of change of Interests of substantial holder01/11/12
GIDAppendix 4C - quarterlyPRICE SENSITIVE30/10/12
GIDFull Approval from FDA to Commence Pivotal StudyPRICE SENSITIVE30/10/12
GIDClinical Results on EndoBarrier Re-implantationPRICE SENSITIVE23/10/12
GIDKey Hormones Affecting Satiety and Blood Sugar ControlPRICE SENSITIVE23/10/12
GIDBriefing Call and Webcast on Financial Results22/10/12
GIDNew Voluntary Escrow Arrangements for Securities04/10/12
GIDEndoBarrier Therapy Offers Improved Glycemic Control02/10/12
GIDAppendix 3B26/09/12
GIDFirst Cases at St. Vincent's Clinic in Sydney, AustraliaPRICE SENSITIVE24/09/12
GIDAppendix 3B05/09/12
GIDHalf year financial accounts 30 June 2012PRICE SENSITIVE30/08/12
GIDFDA Conditional Approval for Pivotal Clinical TrialPRICE SENSITIVE23/08/12
GIDRelease of Securities from Voluntary Escrow21/08/12
GIDAppendix 4C - quarterlyPRICE SENSITIVE30/07/12
GIDGI Dynamics, Inc. Announces Further Commercial ExpansionPRICE SENSITIVE17/07/12
GIDAppendix 3B06/07/12
GIDClinical data on EndoBarrier Therapy for low BMI patients25/06/12
GIDGI Dynamics to Present at the Jefferies Healthcare Confer04/06/12
GIDGore vs. GI Dynamics Lawsuit Summary Judgment RulingPRICE SENSITIVE31/05/12
GIDAppendix 3B31/05/12
GIDResults of Meeting23/05/12
GIDAnnual General Meeting Presentation and Webcast22/05/12
GID2012 AGM Access for Participants by Webcast/Conference Call15/05/12
GIDAppendix 3B15/05/12
GIDAppendix 3B09/05/12
GIDEndoBarrier Therapy Data Published in Annals of Surgery02/05/12
GIDAppendix 4C - quarterlyPRICE SENSITIVE30/04/12
GIDProxy Statement and Notice of 2012 AGM27/04/12
GIDFirst Cases of EndoBarrier Therapy in AustraliaPRICE SENSITIVE19/04/12
GIDGI Dynamics, Inc. Expands Global Commercial Team04/04/12
GIDChange of Director's Interest Notice03/04/12
GIDInformation disclosed under ASX Listing Rule 3.10.5A
30/08/13
GIDRelease of Securities from ASX Escrow
22/08/13
GIDChange in substantial holding
14/08/13
GIDCeasing to be a substantial holder
13/08/13
GIDChange in substantial holding
13/08/13
GIDChange in substantial holding
13/08/13
GIDChange in substantial holding
13/08/13
GIDChange in substantial holding
13/08/13
GIDCleansing Notice
09/08/13
GIDAppendix 3B
09/08/13
GIDGI Dynamics to Present at Canaccord Genuity Conference
08/08/13
GIDChange of Director's Interest Notice
07/08/13
GIDChange of Director's Interest Notice
07/08/13
GIDAppendix 3B
07/08/13
GIDForm604 Notice of change of interests of substantial holder
06/08/13
GIDResults of Meeting
01/08/13
GIDAppendix 4C - quarterly
31/07/13PRICE SENSITIVE
GIDSpecial Meeting of Stockholders Conference Call
24/07/13
GIDSecurity Purchase Plan
12/07/13
GIDNotice of Extraordinary General Meeting/Proxy Form
12/07/13
GIDBecoming a substantial holder
12/07/13
GIDAppendix 3B
11/07/13
GIDForm604 Notice of change of interests of substantial holder
11/07/13
GIDCleansing Notice
10/07/13
GIDDetails of Company Address
05/07/13
GIDGI Dynamics Investor Presentation
03/07/13
GIDGI Dynamics Completes A$57.5 MIillion Private Placement
03/07/13PRICE SENSITIVE
GIDTrading Halt
01/07/13PRICE SENSITIVE
GIDGI Dynamics, Inc. Appoints Distributor for the Middle East
26/06/13PRICE SENSITIVE
GIDFrench Government Approves and Funds Two-Year Clinical Study
19/06/13PRICE SENSITIVE
GIDNew Commercial Centres in the European Union
18/06/13PRICE SENSITIVE
GIDAppendix 3B
06/06/13PRICE SENSITIVE
GIDResults of Meeting
20/05/13
GIDAnnual General Meeting Presentation and Webcast
20/05/13
GID2013 Annual General Meeting Webcast/Conference Call
14/05/13
GIDGI Dynamics names David Maggs, M.D. as Chief Medical Officer
01/05/13
GIDNotice of Annual Meeting/Proxy Form
30/04/13
GIDAppendix 4C - quarterly
30/04/13PRICE SENSITIVE
GIDChange in substantial holding
26/04/13
GIDGI Dynamics, Inc. Reports on Progress of the ENDO Trial
26/04/13PRICE SENSITIVE
GIDAppendix 3B
12/04/13
GIDAnnual Report to shareholders
28/03/13
GIDDetails of Company Address
28/03/13
GIDChange of Directors Interest Notice
19/03/13
GIDAppendix 3B
19/03/13
GIDEndoBarrier Named Product of the Year by BioSpectrum Asia
18/03/13
GIDChange of Director's Interest Notice
12/03/13
GIDChange of Director's Interest Notice
12/03/13
GIDCMS Medical to Distribute EndoBarrier Therapy in Brazil
06/03/13
GIDPreliminary Final Report
28/02/13PRICE SENSITIVE
GIDCommercial Availability of EndoBarrier Therapy in Israel
27/02/13PRICE SENSITIVE
GIDGI Dynamics to Present at the Cowen Healthcare Conference
27/02/13
GIDChange of Director's Interest Notice
26/02/13
GIDChange of Director's Interest Notice
26/02/13
GIDBriefing Call and Webcast on Financial Results for 2012
20/02/13
GIDRelease of Securities from Voluntary Escrow
19/02/13
GIDEndoBarrier Therapy effect on mildly obese patients
01/02/13PRICE SENSITIVE
GIDAppendix 4C - quarterly
30/01/13PRICE SENSITIVE
GIDAppendix 3B
18/01/13
GIDU.S. Pivotal Clinical Trial of EndoBarrier Initiated
15/01/13PRICE SENSITIVE
GIDGI Dynamics Announces Resolution of Litigation with Gore
10/01/13PRICE SENSITIVE
GIDGI Dynamics Announces Research Collaborations
04/01/13PRICE SENSITIVE
GIDChange of Director's Interest Notice
19/12/12
GIDForm604 Notice of Change of interests of substantial holder
03/12/12
GIDRelease of Securities from Voluntary Escrow
27/11/12
GIDAppendix 3B
22/11/12
GIDGID to Present at Lazard and Canaccord Hlthcare Conferences
07/11/12
GIDForm604 Notice of change of interests of substantial holder
02/11/12
GIDForm604 Notice of change of Interests of substantial holder
01/11/12
GIDAppendix 4C - quarterly
30/10/12PRICE SENSITIVE
GIDFull Approval from FDA to Commence Pivotal Study
30/10/12PRICE SENSITIVE
GIDClinical Results on EndoBarrier Re-implantation
23/10/12PRICE SENSITIVE
GIDKey Hormones Affecting Satiety and Blood Sugar Control
23/10/12PRICE SENSITIVE
GIDBriefing Call and Webcast on Financial Results
22/10/12
GIDNew Voluntary Escrow Arrangements for Securities
04/10/12
GIDEndoBarrier Therapy Offers Improved Glycemic Control
02/10/12
GIDAppendix 3B
26/09/12
GIDFirst Cases at St. Vincent's Clinic in Sydney, Australia
24/09/12PRICE SENSITIVE
GIDAppendix 3B
05/09/12
GIDHalf year financial accounts 30 June 2012
30/08/12PRICE SENSITIVE
GIDFDA Conditional Approval for Pivotal Clinical Trial
23/08/12PRICE SENSITIVE
GIDRelease of Securities from Voluntary Escrow
21/08/12
GIDAppendix 4C - quarterly
30/07/12PRICE SENSITIVE
GIDGI Dynamics, Inc. Announces Further Commercial Expansion
17/07/12PRICE SENSITIVE
GIDAppendix 3B
06/07/12
GIDClinical data on EndoBarrier Therapy for low BMI patients
25/06/12
GIDGI Dynamics to Present at the Jefferies Healthcare Confer
04/06/12
GIDGore vs. GI Dynamics Lawsuit Summary Judgment Ruling
31/05/12PRICE SENSITIVE
GIDAppendix 3B
31/05/12
GIDResults of Meeting
23/05/12
GIDAnnual General Meeting Presentation and Webcast
22/05/12
GID2012 AGM Access for Participants by Webcast/Conference Call
15/05/12
GIDAppendix 3B
15/05/12
GIDAppendix 3B
09/05/12
GIDEndoBarrier Therapy Data Published in Annals of Surgery
02/05/12
GIDAppendix 4C - quarterly
30/04/12PRICE SENSITIVE
GIDProxy Statement and Notice of 2012 AGM
27/04/12
GIDFirst Cases of EndoBarrier Therapy in Australia
19/04/12PRICE SENSITIVE
GIDGI Dynamics, Inc. Expands Global Commercial Team
04/04/12
GIDChange of Director's Interest Notice
03/04/12
refresh Created with Sketch. REFRESH
 

Top Stories

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.